• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Medical Devices

  • Print
  • Share
  • E-mail

August 2009 PMA Approvals

Below are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions. This list is generated on a monthly basis.

A PDF document that contains the "Approval letter and Summary of Safety and Effectiveness" is being added to this listing for each PMA. The PMA number will appear as a link if this document is available.

PMA Original Approvals

None.

PMA Supplemental Approvals

APPLICATION NUMBER / DATE of APPROVAL DEVICE TRADE NAME COMPANY NAME CITY, STATE, & ZIP DEVICE DESCRIPTION / INDICATIONS
P840064/S040
8/13/09
135-Day
VISCOAT®, DUOVISC® and DISCOVISC® Ophthalmic Viscosurgical Device. Alcon Research, Ltd.
Fort Worth, TX
76134
Approval for an alternate clean room for aseptic filling as part of a general manufacturing plant expansion.
P860004/S109
8/6/09
Special
Medtronic Model 8472 IsoMed Constant-Flow Pump Medtronic Neurological
Minneapolis, MN
55432
Approval for an Errata insert communicating the incompatibility issue of the sutureless connectors to the Model 8472 IsoMed constant-flow pump.
P860008/S019
8/18/09
Special
CardioCommand Esophageal Bipolar Pacing and Recording Catheter CardioCommand, Inc.
Tampa, FL
33607
Approval for modification of the labeling to enhance the safety in the use of the products.
P880003/S098
8/13/09
Special
FireStar RX PTCA Balloon Dilatation Catheter and DuraStar RX PTCA Balloon Dilatation Catheter Cordis Corporation
Bridgewater, NJ
08807
Approval for the modification of a caution statement in the IFU fo the device.
P890003/S165
8/5/09
135-Day
Prodigy Implantable Pulse Generator (IPG) Medtronic, Inc.
Mounds View, MN
55112
Approval for changing a sterilization specification for finished device manufacturing.
P890047/S028
8/13/09
135-Day
PROVISC® Ophthalmic Viscosurgical Device. Alcon Research, Ltd.
Fort Worth, TX
76134
Approval for an alternate clean room for aseptic filling as part of a general manufacturing plant expansion.
P890064/S020
8/12/09
180-Day
Hybrid Capture® High-Risk HPV DNA Test® and Hybrid Capture® HPV DNA Test® DML 3000™ Microplate Luminometer Qiagen, Inc.
Gaithersburg, MD
20878
Approval for a manufacturing site located at Turner BioSystems in Sunnyvale, California, to manufacture the DML 3000™ Microplate Luminometer which is intended for use with the Hybrid Capture 2 High Risk HPV DNA Test and Hybrid Capture 2 HPV DNA Test.
P930021/S012
8/21/09
180-Day
Straumann® Emdogain Straumann USA
Andover, MA
01810
Approval for a manufacturing site located at IBA Sterigenics Wallonie, S.A., in Verviers, Belgium, for the contract sterilization of the device.
P940015/S015
8/20/09
Real-Time
Synvisc Genzyme Corporation
Cambridge, MA
02142
Approval for labeling changes to the product leaflet/package insert for Synvisc to maintain consistency with wording previously approved for Synvisc-One package inserts.
P950005/S025
8/10/09
180-Day
Celsius RMT Catheter Biosense Webster, Inc.
Diamond Bar, CA
91765
Approval for a three (3) year shelf life for the catheter.
P960040/S175
8/18/09
Real-Time
Confient SW Boston Scientific Corporation
St. Paul, MN
55112
Approval for the Programmer SW Model 2888 v1.08 and Programmer Model 2945 v1.02.
P970008/S045
8/27/09
Real-Time
Urologix Targis® System Urologix, Inc.
Minneapolis, MN
55447
Approval to replace an obsolete connector used in the Targis® and CTC Advance treatment catheters and to improve the connector junction in the CTC Advance catheters
P970012/S052
8/5/09
135-Day
Kappa 400 DR IPG, Kappa 400 SR IPG Medtronic, Inc.
Mounds View, MN
55112
Approval for changing a sterilization specification for finished device manufacturing.
P970051/S048
8/28/09
180-Day
Nucleus 24 Cochlear Implant System Cochlear Americas
Centennial, CO
80111
Approval for the CI512 and CI513 cochlear implants. The CI512 and CI513 implants represent modifications to the Nucleus Freedom Cochlear Implant (also called the CI24RE).
P970051/S049
8/24/09
180-Day
Nucleus Cochlear Implant System Cochlear Americas
Centennial, CO
80111
Approval for the following new components of the cochlear implant system: CP810 Sound Processor, CR110 Remote Assistant, Custom Sound 3.0 programming software.
P980016/S181
8/5/09
135-Day
Marquis Implantable Cardioverter Defibrillator (ICD) Family, Maximo ICD Family, Intrinsic ICD Family, EnTrust ICD Family, Virtuoso ICD Family, Maximo II ICD Family and Secura ICD Family Medtronic, Inc.
Mounds View, MN
55112
Approval for changing a sterilization specification for finished device manufacturing.
P980035/S130
8/5/09
135-Day
Kappa 600/700, 650, 800/900 IPG Family, Sigma IPG Family, Medtronic 350 IPG Series, Relia IPG Family, EnPulse II IPG Family, Adapta/Versa/ Sensia IPG Family and EnRhythm IPG Medtronic, Inc.
Mounds View, MN
55112
Approval for changing a sterilization specification for finished device manufacturing.
P980037/S032
8/7/09
Real-Time
AngioJet® Rheolytic™ Thrombectomy System MEDRAD Interventional/ Possis
Minneapolis, MN
55433
Approval for changes to the high pressure seal component of the AngioJet Ultra Thrombectomy Sets.
P990001/S051
8/5/09
135-Day
Dema Family,
C-series and
T-series
Medtronic, Inc.
Mounds View, MN
55112
Approval for changing a sterilization specification for finished device manufacturing.
P990025/S017
8/10/09
180-Day
Navistar RMT Catheter Biosense Webster, Inc.
Diamond Bar, CA
91765
Approval for a three (3) year shelf life for the catheter.
P990034/S013
8/6/09
Special
Medtronic Model 8472 IsoMed Constant-Flow Pump Medtronic Neuromodulation
Minneapolis, MN
55432
Approval for an Errata insert communicating the incompatibility issue of the sutureless connectors to the Model 8472 IsoMed constant-flow pump.
P990050/S007
8/27/09
Real-Time
WavSTAT® Optical Biopsy System SpectraScience, Inc.
San Diego, CA
92121
Approval for minor design changes due to the hardware parts’ obsolescence, minor labeling changes to reflect the changes in the hardware, and a software change to update the operating system.
P010012/S191
8/18/09
Real-Time
Livian SW Boston Scientific Corporation
St. Paul, MN
55112
Approval for the Programmer SW Model 2888 v1.08 and Programmer Model 2945 v1.02.
P010015/S063
8/5/09
135-Day
InSync Cardiac Resynchronization Therapy Pacing (CRT-P), InSync III CRT-P Medtronic, Inc.
Mounds View, MN
55112
Approval for changing a sterilization specification for finished device manufacturing.
P010030/S011
8/17/09
180-Day
Lifevest Wearable Defibrillator 4000 Zoll Lifecor Corporation
Pittsburgh, PA
15238
Approval for the next generation of wearable defibrillators designed to be smaller, lighter, and more user-friendly. The device, as modified, will be marketed under the trade name Lifevest Wearable Defibrillator and is indicated for adult patients who are at risk for sudden cardiac arrest and are not candidates for or refuse an implantable defibrillator.
P010031/S145
8/5/09
135-Day
InSync ICD,
InSync Marquis ICD, and InSync II Marquis ICD, InSync III Marquis ICD, InSync II Protect ICD, InSync III Protect ICD, InSync Sentry ICD Family, InSync Maximo ICD Family, Concerto Cardiac Resynchronization Therapy-Defibrillator (CRT-D), Maximo II CRT-D, Consulta CRT-D
Medtronic, Inc.
Mounds View, MN
55112
Approval for changing a sterilization specification for finished device manufacturing.
P020014/S024
8/26/09
135-Day
Conceptus Essure™ System Conceptus, Inc.
Mountain View, CA
94041
Approval for an alternate supplier for the wound inner/outer coil (precision wire components) of the device.
P030029/S006
8/20/09
180-Day
ADVIA Centaur Anti-HBs Siemens Healthcare Diagnostics
Tarrytown, NY
10591
Approval fot the ADVIA Centaur System Software Version 4.0.
P030029/S007
8/19/09
180-Day
ADVIA Centaur XP Software v6.0 Anti-HBs Siemens Healthcare Diagnostics
Tarrytown, NY
10591
Approval for the ADVIA Centaur XP system Software Version 6.0.
P030031/S014
8/12/09
180-Day
NaviStar and Celsius ThermoCool® Catheters Biosense Webster
Diamond Bar, CA
91765
Approval of the post-approval study protocol.
P030040/S005
8/20/09
180-Day
ADVIA Centaur Anti-HBc IgM Siemens Healthcare Diagnostics
Tarrytown, NY
10591
Approval fot the ADVIA Centaur System Software Version 4.0.
P030040/S006
8/19/09
180-Day
ADVIA Centaur XP Software v6.0 HBc IgM Siemens Healthcare Diagnostics
Tarrytown, NY
10591
Approval for the ADVIA Centaur XP system Software Version 6.0.
P030049/S005
8/20/09
180-Day
ADVIA Centaur HBsAg (HBs) and HBsAg Confirmatory Siemens Healthcare Diagnostics
Tarrytown, NY
10591
Approval fot the ADVIA Centaur System Software Version 4.0.
P030049/S007
8/19/09
180-Day
ADVIA Centaur XP Software v6.0 HBsAg (HBs) & HBsAg Confirmatory Siemens Healthcare Diagnostics
Tarrytown, NY
10591
Approval for the ADVIA Centaur XP system Software Version 6.0.
P030050/S004
8/17/09
180-Day
Sculptra Sanofi Aventis
Bridgewater, NJ
08807
Approval of the post-approval study protocol.
P030053/S006
8/24/09
180-Day
Memory Gel Silicone Gel-Filled Breast Implant Mentor Corporation
Santa Barbara, CA
93111
Approval for labeling changes after focus group input.
P030056/S002
8/13/09
180-Day
ADVIA Centaur HCV ReadyPack Reagents on the Centaur CP Analyzer
ADVIA Centaur HCV Quality Controls on the Centaur CP Analyzer
Siemens Healthcare Diagnostics
Tarrytown, NY
10591
Approval for the transition of the ADVIA Centaur HCV assay to a new platform in the Centaur family of instruments, the Centaur CP.
ADVIA Centaur HCV ReadyPack Reagents on the Centaur CP Analyzer
The ADVIA Centaur HCV assay is an in vitro diagnostic immunoassay for the qualitative
determination of immunoglobulin G (IgG) antibodies to hepatitis C virus (HCV) in human serum and plasma (EDTA, lithium or sodium heparinized) using the ADVIA Centaur CP system. The assay may be used in conjunction with other serological and clinical information to aid in the
diagnosis of individuals with symptoms of hepatitis and in individuals at risk for hepatitis C
infection.
ADVIA Centaur HCV Quality Controls on the Centaur CP Analyzer
The ADVIA Centaur HCV Quality Controls are intended for in vitro diagnostic use in
monitoring the performance of the HCV assay on the ADVIA Centaur Systems. The performance of the HCV quality controls has not been established with any other anti-HCV assay.
P030056/S005
8/20/09
180-Day
ADVIA Centaur Anti-HCV Siemens Healthcare Diagnostics
Tarrytown, NY
10591
Approval fot the ADVIA Centaur System Software Version 4.0.
P030056/S006
8/19/09
180-Day
ADVIA Centaur XP Software v6.0 HCV Siemens Healthcare Diagnostics
Tarrytown, NY
10591
Approval for the ADVIA Centaur XP system Software Version 6.0.
P040004/S005
8/20/09
180-Day
ADVIA Centaur Anti-HBc Total Siemens Healthcare Diagnostics
Tarrytown, NY
10591
Approval fot the ADVIA Centaur System Software Version 4.0.
P040004/S006
8/19/09
180-Day
ADVIA Centaur XP Software v6.0 HBc Total Siemens Healthcare Diagnostics
Tarrytown, NY
10591
Approval for the ADVIA Centaur XP system Software Version 6.0.
P040013/S014
8/12/09
180-Day
GEM 21S® Growth Factor Enhanced Matrix Luitpold Pharmaceuticals, Inc.
Valley Forge, PA
19403
Approval for a manufacturing site located in Shirley, New York, for the manufacture of the recombinant human platelet-derived growth factor-BB syringe and a quality testing facility at another location in Shirley, New York, for the testing for the raw material, finished product release, and stability with the exception of the bioassay for the drug component of the device.
P040020/S014
8/20/09
180-Day
Acrysof® IQ ReSTOR® Intraocular Lenses (IOLs) +3 D and
+4 D Add Powers
Alcon Research Ltd.
Fort Worth, TX
76134
Approval for changes to the labeling,
revising the Directions for Use (DFU) and patient brochure with updated six-month
follow up data from the clinical investigation for the lenses. The devices, as modified
will be marketed under the trade name Acrysof® IQ ReSTOR® Intraocular Lenses
(IOLs) +3.0 D (Models: SN6AD1 and MN6AD1) and +4.0 D (Models: SN6AD3 and
MN6AD3) Add Powers and is indicated for primary implantation for the visual correction
of aphakia secondary to removal of a cataractous lens in adult patients with or without
presbyopia, who desire near, intermediate and distance vision with increased spectacle
independence. The lens is intended to be placed in the capsular bag.
P040044/S016
8/4/09
Real-Time
Mynx Vascular Closure Device Access Closure, Inc.
Mountain View, CA
94043
Approval for changing the lid component of the Mynx packaging, from Tyvek material to a PETG material lid.
P040048/S008
8/27/09
180-Day
Trilogy AB Acetabular System Zimmer, Inc.
Warsaw, IN
46581
Approval for a manufacturing site located in Marktredwitz, Germany.
P050004/S001
8/28/09
180-Day
EMS Swiss DolorClast® Electro Medical Systems
Nyon, Switzerland
CH-1260
Approval for a manufacturing site located at E.M.S. Electro Medical Systems, SA, Nyon, Switzerland.
P050014/S002
8/11/09
Special
FCRMS Fujifilm Medical System USA, Inc.
Stamford, CT
06902
Approval for:
1) changes in the CNR Weekly check – QC Technologist; 2) change to the Monitor QC – Medical Physicist Test luminance response test;
3) new terminology regarding use of the term “acquisition workstation); and
4) trade name change to “Aspire”.
P050047/S008
8/26/08
Real-Time
Juvederm Hyaluronate Gel Implants Allergan
Santa Barbara, CA
93111
Approval for an addition of 0.4 mL filled syringe configuration.
P060038/S004
8/28/09
135-Day
Mitroflow Aortic Pericardial Heart Valve CarboMedics, Inc.
Arvada, CO
80004
Approval for the addition of a new bovine pericardium supplier used in the manufacture of the device.
P080004/S001
8/7/09
180-Day
Hoya iSpheric™ Model YA-60BB Intraocular Lens Hoya Surgical Optics, Inc.
Chino Hills, CA
91709
Approval to add a new packaging configuration wherein the Hoya Surgical Optics intraocular lenses (IOLs) will be packaged in a disposable, plastic injector.

30-Day Notices (135 Day Supplement was not required)

APPLICATION NUMBER / DATE of APPROVAL DEVICE TRADE NAME COMPANY NAME CITY, STATE, & ZIP DEVICE DESCRIPTION / INDICATIONS
P860004/S110
8/20/09
SynchroMed II Infusion System Medtronic Neuromodulation
Minneapolis, MN
55432
Automation of the step where data is transferred from the Calibration Testing Equipment to FACTORYWorks, the manufacturing software that controls the manufacturing of the device.
P910031/S026
8/26/09
NC Merlin Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter Abbott Vascular, Inc.
Temecula, CA
92591
Change in the equipment used to manufacture the balloons.
P960013/S048
8/28/09
Tendril ST Lead St. Jude Medical, Inc.
Sylmar, CA
91342
Elimination of the plasma priming process.
P960043/S066
8/24/09
Suture Mediated Closure Systems, Percutaneous Vascular Surgical Systems and Associated Accessories Abbott Vascular, Inc.
Redwood City, CA
94063
Additional equipment for use in the packaging stations.
D970012/S068
8/5/09
AMS 700 Inflatable Penile Prosthesis American Medical Systems
Minnetonka, MN
55343
Upgrading of the heating system used in the manufacture of the device.
D970012/S069
8/13/09
AMS 700 Inflatable Penile Prosthesis American Medical Systems
Minnetonka, MN
55343
Implementation of a new duplicate mold.
D970012/S070
8/26/09
AMS 700 Inflatable Penile Prosthesis American Medical Systems
Minnetonka, MN
55343
Replacement of dipping equipment used in the manufacture of the devices.
P980016/S199
8/21/09
Maximo, Secura and Virtuoso II Families of Implantable Cardioverter Defibrillators Medtronic, Inc.
Mounds View, MN
55112
Several changes to D363 IC test.
P980022/S057
8/13/09
MMT-7002 and MMT-7003 Medtronic, Inc.
Diabetes
Northridge, CA
91325
Addition of an additional electroplating line for the sensors.
P980022/S058
8/21/09
Paradigm Real-Time Pump and Guardian Real-Time Monitor – EL Lamp Medtronic, Inc.
Diabetes
Northridge, CA
91325
Changes to the Electro Luminescent Lamp (EL Lamp).
P000053/S025
8/5/09
AMS 800 Artificial Urinary Sphincter American Medical Systems
Minnetonka, MN
55343
Upgrading of the heating system used in the manufacture of the device.
P000053/S026
8/13/09
AMS 800 Artificial Urinary Sphincter American Medical Systems
Minnetonka, MN
55343
Replacement of dipping equipment used in the manufacture of the devices.
P010020/S014
8/13/09
Acticon Neosphincter Artificial Bowel Sphincter American Medical Systems
Minnetonka, MN
55343
Replacement of dipping equipment used in the manufacture of the devices.
P010031/S160
8/21/09
Maximo, Secura and Virtuoso II Families of Implantable Cardioverter Defibrillators Medtronic, Inc.
Mounds View, MN
55112
Several changes to D363 IC test.
P020004/S047
8/21/09
Gore Excluder® AAA Endoprosthesis W.L. Gore & Associates, Inc.
Flagstaff, AZ
86001
Expansion of the manufacturing environment for a component of the final device.
P030017/S094
8/18/09
Precision Spinal Cord Stimulator System (SCS) Boston Scientific Neuromodulation Corporation
Valencia, CA
91355
Modification to the lead assembly process.
P040012/S030
8/5/09
RX Acculink and Acculink Carotid Stent System Abbott Vascular, Inc.
Santa Clara, CA
95054
Expansion of the Acculink manufacturing processes within the existing manufacturing facility in Temecula, California.
P040014/S011
8/28/09
Therapy Cardiac Ablation Catheter St. Jude Medical
Irvine, CA
92614
Change in the proximal component of the ablation catheters.
P040024/S042
8/6/09
Restylane® and Perlane® Injectable Gel Medicis Pharmaceutical Corp.
Scottsdale, AZ
85256
Alternate endotoxin test method.
P040024/S043
8/14/09
Restylane® and Perlane® Injectable Gel Medicis Pharmaceutical Corp.
Scottsdale, AZ
85256
Elimination of the sterilization of garments before use.
P040034/S012
8/28/09
DuraSeal® Dural Sealant System Confluent Surgical, Inc. (dba Covidien)
Waltham, MA
02451
Alternate supplier to provide the functionalized PEG-SG material to the firm for use in the manufacture of the device.
P040042/S016
8/28/09
Therapy Dual 8, Therapy and Safire TX Ablation Catheter St. Jude Medical
Irvine, CA
92614
Change in the proximal component of the ablation catheters.
P040044/S017
8/7/09
Mynx® Vascular Closure Device Access Closure, Inc.
Mountain View, CA
94043
Reduction in the frequency of LAL test sampling for lot release for the device.
P040045/S006
8/7/09
Vistakon® (senofilcon A) Contact Lenses for Extended Wear Johnson & Johnson Vision Care, Inc.
Jacksonville, FL
32256
Change in a Quality Control Test for the finished device.
P040045/S008
8/6/09
Vistakon® (senofilcon A) Contact Lenses Johnson & Johnson Vision Care, Inc.
Jacksonville, FL
32256
Change in a quality control test method for the finished device.
P050006/S013
8/7/09
Gore HELEX™ Septal Occluder W.L. Gore & Associates, Inc.
Flagstaff, AZ
86001
Relocation of manufacturing from one facility to another within the same registered establishment.
P050007/S017
8/13/09
StarClose SE® Vascular Closure System Abbott Vascular, Inc.
Redwood, CA
94063
Addition of an alternate assembly step to the manufacturing process for the obturator release rod assembly.
P050007/S018
8/24/09
StarClose and StarClose SE® Vascular Closure Systems Abbott Vascular, Inc.
Redwood City, CA
94063
Additional equipment for use in the packaging stations.
P050020/S018
8/21/09
Freestyle Navigator® Continuous Glucose Monitoring System Abbott Diabetes Care, Inc.
Alameda, CA
94502
Changes to the parameters of the transmitter bottom housing mold.
P060033/S037
8/14/09
Endeavor Zotarolimus-Eluting Coronary Stent Systems Medtronic Vascular
Santa Rosa, CA
95403
Additional automation of the balloon sub-assembly manufacturing process.
P060038/S005
8/7/09
Mitroflow Aortic Pericardial Heart Valve CarboMedics, Inc.
Arvada, CO
80004
Change in the minimum exposure time for the sterilization process of the device.
P060038/S006
8/14/09
Mitroflow Aortic Pericardial Heart Valve CarboMedics, Inc.
Arvada, CO
80004
Change to the base seam stitching pattern.
P070009/S005
8/25/09
Realize™ Adjustable Gastric Band-C Ethicon Endo-Surgery, Inc.
Cincinnati, OH
45242
Addition of an alternate component supplier.
P070015/S023
8/26/09
Xience V® OTW Everolimus Eluting Coronary Stent System (EECSS) Abbott Vascular, Inc.
Temecula, CA
92592
Replacement of the E-beam irradiation equipment.

Summary of PMA Originals & Supplements Approved
Originals: 0
Supplements: 50

Summary of PMA Originals Under Review
Total Under Review: 73
Total Active: 40
Total On Hold: 33
Number Greater Than 180 Days: 5

Summary of PMA Supplements Under Review
Total Under Review: 436
Total Active: 293
Total On Hold: 143
Number Greater Than 180 Days: 19

Summary of All PMA Submissions Received
Originals: 4
Supplements: 37

Summary of PMA Supplement PMA Approval/Denial Decision Times
Number of Approvals: 50
Number of Denials: 0
Average Days Fr Receipt to Decision (Total Time): 162.6
FDA Time: 119 Days MFR Time: 43.6 Days

-
-